| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 9 |
| 1 | ACETAMINOPHEN | 8 |
| 2 | METHOTREXATE | 8 |
| 3 | SECUKINUMAB | 8 |
| 4 | CELECOXIB | 7 |
| 5 | LEFLUNOMIDE | 7 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 5 |
| 7 | ALBUTEROL SULFATE | 5 |
| 8 | CETIRIZINE | 5 |
| 9 | CETIRIZINE HYDROCHLORIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHACHOLINE CHLORIDE | 1 | 0.0143 |
| 1 | CLEMATIS VITALBA FLOS, HELIANTHEMUM NUMMULARIUM FLOS, IMPATIENS GLANDULIFERA FLOS, ORNITHOGALUM UMBELLATUM FLOS, PRUNUS CERASIFERA FLOS | 1 | 0.0065 |
| 2 | VANDETANIB | 1 | 0.0006 |
| 3 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 2 | 0.0005 |
| 4 | CALCIFEDIOL | 1 | 0.0004 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 6 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 7 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 8 | LOTEPREDNOL ETABONATE | 1 | 0.0002 |
| 9 | ELOSULFASE ALFA | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 2 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Potassium Binder [EPC] | 1 | 0.0001 |
| 5 | Antirheumatic Agent [EPC] | 7 | 0.0001 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Expectorant [EPC] | 5 | 0.0000 |